Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu

Dr. Michael Schmück-Henneresse

Charité - Universitätsmedizin Berlin

You are here:


  • T cell migration and activation in autoimmunity, transplantation and cancer
  • T cell memory differentiation
  • Next generation regulatory and antigen-specific T cell products
  • CRISPR-Cas-mediated targeted gene modification of T cells
  • Immunopathology issues related to CRISPR-Cas-mediated gene editing
  • Development of cell therapy products (within the GMP pipeline)
  • Immune monitoring

Additional information

Dr. rer. medic. Michael Schmück-Henneresse is group leader at the BIH Center for Regenerative Therapies (BCRT).

For more information, see WG Schmück-Henneresse on the Concept page, which provides information about the project, structure and working groups of BeCAT.